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Abstract
It is well established that kisspeptin signaling is necessary for the onset of puberty in laboratory animals. However, the role that kisspeptin
may have in regulating puberty in large domestic animals is unknown. We tested the hypothesis that either central or peripheral infusion
of kisspeptin would stimulate gonadotropin and GH secretion in prepubertal gilts. In experiment 1, prepubertal gilts were fitted with
i.c.v. cannula and indwelling jugular catheters. Animals were randomly assigned to receive 0, 10, or 100 mg kisspeptin in saline.
In experiment 2, prepubertal gilts, fitted with indwelling jugular catheters, randomly received 0, 1, 2.5, or 5 mg kisspeptin in saline
intravenously. Serial blood samples were collected every 15 min for 3 h before and 5 h after infusions, and serum concentrations of LH,
FSH, and GH were determined. Mean concentrations of LH and FSH remained at basal levels for control animals but were increased
(P!0.001) for animals receiving i.c.v. infusion of kisspeptin. Area under the LH and FSH curves following i.c.v. infusion of kisspeptin
increased (P!0.001) in a dose-dependent manner. Concentrations of GH were unaffected by i.c.v. treatment. Peripheral administration
of kisspeptin increased (P!0.05) serum concentrations of LH but not FSH or GH. Thus, kisspeptin can activate gonadotropic but not
somatotropic hormone secretion in prepubertal gilts. The present data support the concept that kisspeptin plays a role in the mechanism
involved in initiating puberty in swine.
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Introduction
Gonadotropin-releasing hormone (GnRH) is secreted
from hypothalamic neurons and is transported through
the hypophyseal portal veins to the anterior pituitary
gland where it stimulates synthesis and secretion of
luteinizing hormone and follicle-stimulating hormone
(LH and FSH; Schally et al. 1971). These pituitary
gonadotropins are essential for normal gonadal develop-
ment and function (Brinkley 1981, Desjardins 1981,
Clarke et al. 1983, Gharib et al. 1990). In mammals, the
components of the hypothalamic–pituitary–gonadal
(HPG) axis are functional prior to the normal onset of
puberty (Lutz et al. 1984, Urbanski & Ojeda 1987),
which is thought to be brought about by central and
peripheral changes that lead to increased activity of the
GnRH pulse generator (Pelletier et al. 1981, Foster et al.
1985, Plant et al. 1989). However, the mechanisms
within the brain that regulate the proper temporal release
of GnRH from hypothalamic neurons to initiate puberty
remain largely unknown.
In general, increased excitatory signals and reduced
inhibitory signals to the GnRH neuronal network prompt
the onset of puberty (Ojeda & Urbanski 1994). With
regard to the former, kisspeptins have been implicated as
potent stimulators of the gonadotropic axis (Gottsch et al.
2004, Dhillo et al. 2005). Structurally related peptides,
kisspeptins, are products of the KISS1 gene (Kotani et al.
2001, Ohtaki et al. 2001). Synthesized as a pre-
prohormone, it is cleaved to liberate a 54 amino acid
peptide that can be proteolytically processed (Takino
et al. 2003) to shorter variants; all of which share the same
amidated C terminus and retain full biological activity
(Kotani et al. 2001, Ohtaki et al. 2001). Kisspeptin, acting
through its cognate G-protein coupled receptor GPR54/
KISS1R (Kotani et al. 2001), is thought to be an important
determinant in the onset of puberty (Seminara & Kaiser
2005). Indeed, Gpr54/Kiss1r knockout mice failed to
initiate puberty (Funes et al. 2003, Seminara et al. 2003)
and naturally occurring mutations in GPR54/KISS1R
result in idiopathic hypogonadotropic hypogonadism in
humans (de Roux et al. 2003, Seminara et al. 2003,
Semple et al. 2005). Expression of the KISS1 and GPR54/
KISS1R genes is both hormonally and developmentally
regulated in the rodent (Navarro et al. 2004a, 2004b).
Kisspeptin stimulates LH secretion (Matsui et al. 2004,
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Thompson et al. 2004, Navarro et al. 2005b) in a GnRH-
dependent manner (Gottsch et al. 2004, Shahab et al.
2005, Arreguin- Arevalo et al. 2007). It has been
demonstrated that kisspeptin acts directly on GnRH
neurons to stimulate GnRH and gonadoroptin secretion
(Thompson et al. 2004, Irwig et al. 2005, Messager et al.
2005). This has culminated in the establishment of a role
for kisspeptin in the initiation of puberty in the rodent and
primate (Shahab et al. 2005, Castellano et al. 2006). Data
are available with regard to the effects of kisspeptin on LH
secretion in the adult ewe (Messager et al. 2005,
Arreguin-Arevalo et al. 2007, Caraty et al. 2007).
However, the possible role of kisspeptin in mediating
the onset of puberty in large domestic species, in
particular the pig, has yet to be determined.
In the present study, we hypothesize that kisspeptin is
an important regulator of gonadotropin secretion in the
pig. To test this hypothesis, we administered kisspeptin
either centrally or peripherally to prepubertal gilts and
measured changes in gonadotropin secretion. Because
the occurrence of puberty in the pig is directed by
mechanisms in which the HPG axis regulates both
gonadal function and growth (Barb et al. 1999), we
tested the hypothesis that kisspeptin would modulate
growth hormone (GH) secretion in the prepubertal gilt.
Results
Experiment 1
A treatment–time interaction (P!0.001) was detected
for serum concentrations of LH. Prior to the i.c.v.
infusion, serum concentrations of LH were similar for
all animals (0.25G0.03 ng/ml). Following i.c.v. treat-
ment, LH concentrations remained at basal levels for the
control animals but were increased (P!0.001) for
animals receiving either 10 or 100 mg kisspeptin (Figs 1
and 2). Mean concentration, peak concentration, and
area under the curve (AUC) of serum LH were greater
(P!0.001) in period 2, following i.c.v. infusion, for
kisspeptin-treated animals compared with saline-treated
controls (Fig. 2). Mean concentration and AUC of serum
LH in period 2 were greater (P!0.01) for animals treated
with the 100 mg dose of kisspeptin compared with the
10 mg dose (Fig. 2), but peak concentrations of serum LH
in period 2 were similar (Fig. 2). All animals responded
to a single i.v. bolus infusion of GnRH in period 3 with
elevated serum LH (Fig. 1). Mean concentration and
peak concentration of serum LH in period 3 were greater
(P!0.05) for control animals compared with kisspeptin-
treated animals (Fig. 2). Animals treated with the 10 mg
dose of kisspeptin had decreased (P!0.05) AUC
Figure 1 Serum concentrations of LH and FSH
(meansGS.E.M.) for prepubertal gilts receiving
i.c.v. infusion of saline or either 10 or 100 mg
kisspeptin (Kiss). Period 1 is the 3 h prior to i.c.v.
treatment; period 2 is the 3 h after i.c.v. treatment;
period 3 is the 90 min following an i.v. injection
of 100 mg GnRH. A treatment–time interaction
was detected for LH (P!0.001) and FSH
(P!0.001). *Times at which effects of treatment
were different from saline-treated control animals
(P!0.05). #Times at which effects of treatment
tended to be different from saline-treated control
animals (P!0.10).
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following GnRH when compared with control animals
treated with GnRH (Fig. 2). Area under the LH curve
following GnRH was similar for control animals and
those treated with the 100 mg dose of kisspeptin (Fig. 2),
since serum concentrations of LH in the kisspeptin-
treated animals were still above baseline at the
beginning of period 3 (Fig. 1).
Similar to LH, there was a treatment–time interaction
(P!0.001) for the effect of i.c.v. kisspeptin on FSH
secretion (Fig. 1). Mean concentration, peak concen-
tration, and AUC of serum FSH were increased
(P!0.001) in period 2 for kisspeptin-treated animals in
a dose-dependent manner when compared with control
animals (Fig. 3). Serum FSH concentrations were
increased (P!0.05) in control animals following GnRH
treatment in period 3 (Fig. 1). Serum concentrations of
FSH had not returned to baseline levels in the kisspeptin-
treated animals at the beginning of period 3 (Fig. 1), thus
there was no difference in the parameters of FSH
secretion between control and kisspeptin-treated
animals following GnRH infusion (Fig. 3).
An expected variation in secretory patterns of GH
between animals was observed; however, serum
concentrations of GH were not affected by i.c.v.
treatment (Fig. 4). Mean concentrations of GH in serum
following i.c.v. infusion were 4.15G1.9, 2.33G0.5,
and 2.96G1.1 ng/ml for controls, Kiss 10 mg, and Kiss
100 mg treated animals respectively.
Experiment 2
There was a treatment–time interaction (P!0.001) for
serum concentrations of LH. Serum LH concentrations
increased following i.v. infusion in all kisspeptin-treated
animals (Fig. 5). Compared with period 1, mean
concentration, peak concentration, and AUC of serum
LH of control animals were unchanged in period 2 but
were greater (P!0.05) for all kisspeptin-treated animals
(Fig. 7). Mean LH for animals treated with 5 mg kisspeptin
tended (P!0.1) to be greater than for animals treated with
1 mg kisspeptin (Fig. 7). Area under the LH curve
increased (P!0.05) in a linear fashion with increasing
dose of kisspeptin (Fig. 7), which resulted from more
sustained release of LH following the higher doses (Fig. 5).
Figure 2 Mean LH, peak LH, and area under the curve (AUC) of serum
LH for prepubertal gilts receiving i.c.v. infusion of saline or either 10 or
100 mg kisspeptin (Kiss). Data in period 1 are from the 3 h prior to i.c.v.
treatment; data in period 2 are from the 3 h after i.c.v. treatment; and
data in period 3 are from the 90 min following an i.v. infusion of 100 mg
GnRH. Data are presented as meanGS.E.M. a,bMeans within a period
differ between treatments (P!0.05).
Figure 3 Mean FSH, peak FSH, and area under the curve (AUC) of
serum FSH for prepubertal gilts receiving i.c.v. infusion of saline or
either 10 or 100 mg kisspeptin (Kiss). Data in period 1 are from the 3 h
prior to i.c.v. treatment; data in period 2 are from the 3 h after i.c.v.
treatment; and data in period 3 are from the 90 min following an i.v.
infusion of 100 mg GnRH. Data are presented as meanGS.E.M. a,bMeans
within a period differ between treatments (P!0.05).
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Intravenous infusion of kisspeptin at the highest dose
tended (PZ0.08) to increase serum concentrations of
FSH at 45–90 min after treatment (Fig. 6). There was
neither a treatment nor treatment–period interaction on
parameters of FSH secretion (Fig. 7). However, the overall
mean in period 2 was greater (P!0.05) for peak
FSH (2.29G0.18 vs 2.56G0.18 ng/ml for periods 1
and 2 respectively) and AUC of FSH (343G33 vs
395G33 ng/ml for periods 1 and 2 respectively) than in
period 1. Concentrations of GH in serum were similar for
all animals and were unchanged by i.v. infusion of 1, 2.5,
or 5 mg kisspeptin (Table 1).
Discussion
We report here for the first time that central infusion of
kisspeptin to prepubertal gilts rapidly induces LH
secretion. This strongly supports the concept that the
role kisspeptin has in regulating the onset of puberty in
the rodent (Navarro et al. 2004a, 2004b, Castellano et al.
2006) and primate (Plant et al. 2006) may be conserved
in the domestic pig, which is an important biomedical
model (Tumbleson 1986, Lunney 2007). The AUC,
which reflects the integrated pattern of LH secretion,
was increased by kisspeptin in a dose-dependent
manner. The 10 mg dose (7.5 nmol) of kisspeptin resulted
Figure 4 Serum GH concentrations for prepubertal
gilts receiving i.c.v. infusion of saline or either 10 or
100 mg kisspeptin (Kiss). Data of three representative
animals from each treatment are shown. The dashed
vertical line indicates the time at which i.c.v.
treatments were administered. There was no
treatment–time interaction detected.
Figure 5 Serum LH concentrations (meanG
S.E.M.) for prepubertal gilts receiving i.v.
infusions of saline or either 1, 2.5, or 5 mg
kisspeptin (Kiss). A treatment–time interaction
was detected (P!0.01). *Times at which
effects of treatment were different from saline-
treated control animals (P!0.05).
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in a rapid pulse of LH that gradually declined over the
next 3 h, whereas the pulse of LH induced by 100 mg
(75 nmol) kisspeptin persisted throughout the sampling
period. Presumably, this reflects the kisspeptin-induced
pattern of GnRH secretion. Kisspeptin has been shown to
stimulate the in vitro release of GnRH from hypo-
thalamic explants of rats (Thompson et al. 2004), and
central infusion of ovariectomized ewes with 50 nmol
kisspeptin over a 4-h period caused the sustained
secretion of GnRH into the cerebrospinal fluid
Figure 6 Serum FSH concentrations (meanGS.E.M.)
for prepubertal gilts receiving i.v. infusions of
saline or either 1, 2.5, or 5 mg kisspeptin (Kiss).
A tendency for a treatment–time interaction was
detected (PZ0.08). #Times at which effects of
treatment tended to be different from saline-
treated control animals (P!0.10).
Figure 7 Mean concentration, peak concentration,
and area under the curve (AUC) of serum LH and
FSH for prepubertal gilts receiving i.v. infusion of
saline or either 1, 2.5, or 5 mg kisspeptin (Kiss).
Data in period 1 are from of the 3 h prior to
treatment and data in period 2 are from the 3 h after
treatment. Data are presented as meanGS.E.M.
a,b,cMeans within a period differ between treat-
ments (P!0.05).
Kisspeptin and hormone secretion in gilts 883
www.reproduction-online.org Reproduction (2008) 135 879–887
concomitantly with elevated serum concentrations of LH
(Messager et al. 2005). We cannot preclude, however,
that the pattern of LH secretion observed here might be
caused by alterations in GnRH pulse frequency or
amplitude. Whether or not kisspeptin regulates the
GnRH pulse generator is not presently known. Regard-
less, pituitary function was intact in these animals
as indicated by the increased LH secretion in control
pigs following an i.v. infusion of GnRH in period 3.
The GnRH-induced release of LH in animals that had
received i.c.v. infusions of kisspeptin was reduced when
compared with that of the control animals that had
received i.c.v. infusion of saline. In view of the prolonged
stimulation of LH release following kisspeptin treatment,
this reduced response to GnRH likely reflects a reduction
in the releasable pool of LH.
In order to determine whether peripheral adminis-
tration of kisspeptin could induce LH secretion in
prepubertal pigs, we administered an i.v. bolus of
kisspeptin at three different doses. All three doses tested
were able to elevate secretion of LH in these animals.
This is substantiated by reports in rodents and monkeys
which demonstrate kisspeptin stimulates LH secretion
when given either centrally or peripherally (Matsui et al.
2004, Navarro et al. 2005b, Shahab et al. 2005). At the
time our study was conducted, it was reported that i.v.
administration of !3 mg kisspeptin to ovariectomized
ewes resulted in somewhat variable LH release
(Arreguin-Arevalo et al. 2007). Since the completion of
our study, it has now been shown that i.v. administration
of kisspeptin at doses of !1 mg can reliably elicit LH
secretion, at least in the ovariectomized estradiol-treated
ewe (Caraty et al. 2007). In the present study, the
magnitude of LH release was similar for all doses of
kisspeptin but the duration was longer with increasing
dose. Whether or not i.v. infusion of kisspeptin at!1 mg
can reliably induce LH secretion in the pig warrants
further investigation.
Information regarding the effects of kisspeptin on FSH
secretion is limited. We demonstrate that the central
administration of kisspeptin to prepubertal gilts
increased serum concentrations of FSH. This effect
of kisspeptin on FSH secretion in the pig is in agreement
with reports in rodents (Matsui et al. 2004, Thompson
et al. 2004, Navarro et al. 2005a) and primates
(Plant et al. 2006). The increase in FSH induced
by kisspeptin showed more gradual onset and the
magnitude was less than that of LH. The ED50 of
kisspeptin to release FSH has been estimated to bew100
times higher than that for LH in rats (Navarro et al.
2005a). This may reflect the fact that FSH is not wholly
under the control of GnRH (Kile & Nett 1994, Phillips
2005). Despite a clear effect of i.c.v.-infused kisspeptin
on FSH secretion, i.v. infusion only tended to alter FSH
secretory patterns in prepubertal gilts infused with the
highest dose of kisspeptin. This is similar to observations
in the ovariectomized ewe (Arreguin-Arevalo et al.
2007). However, it was recently reported that doses of
kisspeptin up to tenfold less than used in our experiment
were able to stimulate FSH secretion in ovariectomized
estradiol-treated ewes (Caraty et al. 2007). Differences in
species and physiological status of the animals may
account for differing results when kisspeptin is infused
intravenously.
Concentrations of FSH in serum remained elevated at
the end of the 3 h sampling period in the animals
receiving i.c.v. infusion of 100 mg kisspeptin, despite the
fact that LH in those animals was declining. Interestingly,
a similar observation has recently been reported in
ovariectomized estradiol-treated ewes (Caraty et al.
2007). In the present experiment, we were unable to
determine whether this is due to a true change in
secretion, or to the longer half-life of FSH (Macdonald
et al. 2007). In the pig, circulating concentrations of LH
are reduced more rapidly than those of FSH after a bolus
GnRH infusion (Wise et al. 1996). Nonetheless, the initial
pattern of FSH secretion induced by i.c.v. infusion of
kisspeptin is similar to that caused by i.v. infusion of
GnRH in the control animals. This supports the concept
that the primary mechanism of kisspeptin-induced FSH
secretion is mediated through the GnRH neuronal
network (Thompson et al. 2004, Irwig et al. 2005,
Messager et al. 2005).
During preparation of this manuscript, it was reported
that i.v. administration of kisspeptin stimulated GH
secretion in prepubertal heifer calves (Kadokawa et al.
2008). Indeed, age-related changes in serum concen-
trations of GH occur in the pig but typically decline
as the animal is approaching puberty (Machlin et al.
1968, Klindt & Stone 1984, Dubreuil et al. 1987).
We found no effect of either central or peripheral
administration of kisspeptin on secretion of GH in
the present study. Divergence with regard to kisspeptin’s
actions on GH secretion may be related to species
differences. However, our experiment included a true
control group, which may have allowed us to more
Table 1 Effect of i.v. administration of kisspeptin (Kiss) on serum concentrations of growth hormone (GH; ng/ml) in prepubertal gilts.
Treatment P value
Perioda Control Kiss 1 mg Kiss 2.5 mg Kiss 5 mg S.E.M.b Treatment Period TreatmentKperiod
1 3.11 3.17 2.92 3.90 0.39 0.16 0.56 0.70
2 2.56 3.23 2.74 4.03 0.47
aPeriod 1, before treatment; period 2, after treatment. bS.E.M., overall, S.E.M. within treatment.
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accurately delineate the effect of kisspeptin on GH
secretion in the pig. The inclusion of saline-treated
controls clearly illustrate that, in our hands, kisspeptin
does not modulate the secretion of GH in the prepubertal
pig, and agrees with observations in monkeys (Plant
personal communication).
In conclusion, here we report that kisspeptin can
activate the gonadotropic axis in the prepubertal pig.
The ability of kisspeptin to stimulate hormone secretion
from the anterior pituitary gland of the pig seems to be
specific for LH and FSH and did extend to GH in this
study. We presently do not know whether other anterior
pituitary hormones in the pig are affected by kisspeptin.
Our data are consistent with the idea that kisspeptin’s
actions on gonadotropin secretion are mediated
primarily through modulating secretion of GnRH and
support the concept that kisspeptin plays an important
role in regulating puberty.
Materials and Methods
All procedures involving animals were approved by the
Institutional Animal Care and Use Committee of The University
of Georgia. Prepubertal gilts (sow line C42, boar line 280; PIC,
Franklin, KY, USA) weighing 67.6G7.2 kg (meanGS.D.) and
130-day age were used. Animals were born and reared at the
Swine Research Center at The University of Georgia. During
experiments, animals were moved to a Large Animal Research
Unit, where they were kept in individual pens under controlled
temperature (22 8C) and had access to feed and water ad libitum
unless otherwise noted. The diet was formulated to meet
National Research Council guidelines (NRC 1988) for growing
swine. Kisspeptin consisted of the ten C-terminal amino acids
of the murine peptide and was obtained from GenScript Corp.
(Scotch Plains, NJ, USA). GnRH was obtained from Sigma or
Merial Limited (Cystorelin; Iselin, NJ, USA).
Experiment 1
Animals (nZ14) were surgically fitted with a lateral i.c.v.
cannula using a steriotaxic procedure described previously
(Estienne et al. 1990, Barb et al. 1993). Placement of the i.c.v.
cannula of each animal was verified by X-ray. At least 1 week
after the placement of i.c.v. cannula, and 24 h prior to
treatment, all animals were fitted with indwelling jugular
catheters (Barb et al. 1982). Animals were randomly assigned
to one of three groups. Control animals received 150 ml PBS.
The other groups received either 10 or 100 mg kisspeptin in
150 ml PBS. Doses of kisspeptin were based on our previous
experience with i.c.v. administration of hormones to the pigs
(Barb et al. 2004, Barb & Barrett 2005). Serial blood samples
were drawn every 15 min for 3 h before (period 1) and 3 h after
(period 2) i.c.v. treatment, and for 90 min (period 3) following
an i.v. bolus infusion of 100 mg GnRH. The time from the end of
period 2 to the beginning of period 3 was 15–45 min. The
inclusion of the GnRH treatment was to verify that pituitary
function was intact and that LH secretion could in fact be
induced in these prepubertal gilts. One week later, the
experiment was replicated with animals reassigned to treat-
ment so that no animal received the same treatment a second
time, resulting in eight pigs for the control treatment and ten
pigs for each dose of kisspeptin. Gilts were killed and the
ovaries were subjected to gross inspection to confirm the
absence of luteal structures.
Experiment 2
Experiment 2 was conducted with six prepubertal gilts in each
treatment group to determine the response to increasing doses
of kisspeptin administered as a single bolus i.v. infusion.
Animals were fitted with indwelling jugular catheters the day
prior to the experiment. Animals received 1, 2.5, or 5 mg
kisspeptin in 3 ml PBS or 3 ml PBS alone for the control
animals. Doses were chosen in part based on the reported
effective dose in sheep (Arreguin-Arevalo et al. 2007). At
0730 h, feeders were removed from pens and blood sampling
started at 0800 h. Serial blood samples were drawn every
15 min for 3 h before (period 1) and 5 h after (period 2)
treatment. Feeders were returned to all pens after the last blood
sample was drawn.
Hormone analysis
Blood was allowed to clot for 1 h at room temperature and then
4 8C overnight. Serum was separated by centrifugation and
stored at K20 8C for subsequent analysis of LH (Kesner et al.
1987) and FSH (Trout et al. 1992) by RIA. The reference
standard for LH (AFP-10506A) and FSH (AFP-10640B) was
provided by Dr A F Parlow, Scientific Director of the NIH,
NIDDK, National Hormone and Peptide Program. Sensitivity of
the assays was 0.15 and 0.2 ng/ml for LH and FSH respectively.
Intra- and inter-assay coefficient of variation (CV) of LH assays
were 7.9 and 9.8% respectively. Four pools of porcine serum
with FSH concentrations that ranged from 1 to 3 ng/ml were
included in each assay; these had intra-assay CV that ranged
from 4 to 16%. Serum concentrations of GH were determined
using a porcine RIA kit (Millipore Corp., Billerica, MA, USA).
Sensitivity of the assay was 1 ng/ml and intra- and inter-assay
CV were 8.6 and 13.4% respectively.
Statistical analysis
To determine the effect of kisspeptin on serum concentrations
of LH, FSH, and GH, data were subjected to generalized least
squares ANOVA with repeated measures using the MIXED
procedure of SAS (1999). The model included replicate,
treatment, time, and all first- and second-order interactions,
with a compound symmetric function used to model the
covariance structure for the repeated measures. If a significant
(P!0.05) treatment–time interaction was detected, the simple
effects of treatment within a time were compared using the
SLICE option of the LSMEANS statement of SAS. Mean
concentration, peak concentration, and AUC of serum LH
and FSH at fixed periods were subjected to generalized least
squares ANOVA with repeated measures. In experiment 1,
Kisspeptin and hormone secretion in gilts 885
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periods 1 and 2 were defined as the 3 h before and 3 h after
i.c.v. treatment respectively. Period 3 was defined as the 90 min
following i.v. infusion of GnRH. In experiment 2, periods 1 and
2 were defined the same as in experiment 1. The model
included replicate, treatment, period, and all first- and second-
order interactions, with a compound symmetric function used
to model the covariance structure for the repeated measures.
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